However there are also reports that pharmacological (roscovitine) or siRNA inhibition of CDK5 enhances the proliferation of the breast cancer cell lines MCF-7 and MDA-MB321, while application of carboplatin, a chemotherapeutic used in the treatment of breast cancer, induces CDK5 activation [44]. The gene discussed is CDK5; the disease is breast carcinoma.